
Validea's guru fundamental report indicates DOVER CORP (DOV), a large-cap growth stock in Misc. Capital Goods, scores 75% using its Warren Buffett-inspired 'Patient Investor' model. This rating, while below the 80% threshold for 'some interest,' highlights DOV's strong fundamentals, including predictable earnings, low debt, robust free cash flow, and effective use of retained earnings, despite a 'Fail' on Return on Total Capital. The assessment suggests DOV aligns well with long-term, value-oriented investment criteria.
Dover Corp (DOV) exhibits significant fundamental strength based on Validea's 'Patient Investor' model, which emulates Warren Buffett's strategy, scoring a solid 75%. Although this rating is just below the 80% threshold for 'some interest,' it underscores the company's alignment with long-term value criteria. The analysis confirms DOV's predictable earnings, manageable debt service, high return on equity, and strong free cash flow generation. Moreover, the company earns a 'PASS' for its use of retained earnings and its share repurchase program, signaling efficient and shareholder-friendly capital allocation. The primary weakness identified is its 'FAIL' on Return on Total Capital (ROTC), which indicates a potential inefficiency in generating profits from its entire capital base. For a large-cap stock in the Miscellaneous Capital Goods industry, DOV presents a profile of a durable business with multiple positive fundamentals, tempered by a specific concern around capital efficiency.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.65
Ticker Sentiment